Performance evaluation of the Xpert MTB/XDR test for the detection of drug resistance to Mycobacterium tuberculosis among people diagnosed with tuberculosis in South Africa
Journal of Clinical Microbiology · 14.08.2024 · 62 (8)
DOI: 10.1128/jcm.00229-24 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 14.08.2024. Verfasst von Shaheed Vally Omar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Tuberculosis, National TB Reference Laboratory, National Institute for Communicable Diseases, a division of the National Health Laboratory…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Microbial Sensitivity Tests, Sensitivity and Specificity. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Drug-resistant tuberculosis (TB) poses a significant public health concern in South Africa due to its complexity in diagnosis, treatment, and management. This study assessed the diagnostic performance of the Xpert MTB/XDR test for detecting drug resistance in patients with TB by using archived sputum sediments. This study analyzed 322 samples collected from patients diagnosed with TB between 2016 and 2019 across South Africa, previously characterized by phenotypic and genotypic methods. The Xpert MTB/XDR test was evaluated for its ability to detect resistance to isoniazid (INH), ethionamide (ETH), fluoroquinolones (FLQ), and second-line injectable drugs (SLIDs) compared with phenotypic drug susceptibility testing (pDST) and whole-genome sequencing (WGS). Culture, Xpert MTB/RIF Ultra, and Xpert MTB/RIF (G4) tests were performed to determine sensitivity and agreement with this test for TB detection. The sensitivities using a composite reference standard, pDST, and sequencing were >90% for INH, FLQ, amikacin (AMK), kanamycin (KAN), and capreomycin (CAP) resistance, meeting the WHO target product profile criteria for this class. A lower sensitivity of 65.9% (95% CI: 57.1–73.6) for ETH resistance was observed. The Xpert MTB/XDR showed a sensitivity of 98.3% (95% CI: 96.1–99.3) and specificity of 100% (95% CI: 86.7–100) compared with culture, a positive percent agreement (PPA) of 98.8% (95% CI: 93.7–99.8) and negative percent agreement (NPA) of 100.0% (95% CI: 78.5–100.0) compared with G4, and a PPA of 99.5% (95% CI: 97.3–99.9) and NPA of 100.0% (95% CI: 78.5–100.0) compared with Xpert MTB/RIF Ultra for detecting Mycobacterium tuberculosis . The test offers a promising solution for the rapid detection of drug-resistant TB and could significantly enhance control efforts in this setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Tuberculosis, National TB Reference Laboratory, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa.
- Cepheid (PTY) LTD, Johannesburg, South Africa.
- Cepheid, Sunnyvale, California, USA.
ORCID-Profile: Shaheed Vally Omar, Gail Louw, Farzana Ismail, Dumsani Ngcamu, Thabisile Gwala, Lavania Joseph
Zitieren
APA
Omar, S. V., Louw, G., Ismail, F., Liu, X., Ngcamu, D., Gwala, T., van der Meulen, M., & Joseph, L. (2024). Performance evaluation of the Xpert MTB/XDR test for the detection of drug resistance to Mycobacterium tuberculosis among people diagnosed with tuberculosis in South Africa. Journal of Clinical Microbiology, 62(8). https://doi.org/10.1128/jcm.00229-24
Vancouver
Omar SV, Louw G, Ismail F, Liu X, Ngcamu D, Gwala T, et al. Performance evaluation of the Xpert MTB/XDR test for the detection of drug resistance to Mycobacterium tuberculosis among people diagnosed with tuberculosis in South Africa. Journal of Clinical Microbiology. 2024;62(8). doi:10.1128/jcm.00229-24
BibTeX
@article{Omar2024,
author = {Omar, Shaheed Vally and Louw, Gail and Ismail, Farzana and Liu, Xiaohong and Ngcamu, Dumsani and Gwala, Thabisile and van der Meulen, Minty and Joseph, Lavania},
title = {Performance evaluation of the Xpert MTB/XDR test for the detection of drug resistance to Mycobacterium tuberculosis among people diagnosed with tuberculosis in South Africa},
journal = {Journal of Clinical Microbiology},
year = {2024},
volume = {62},
number = {8},
doi = {10.1128/jcm.00229-24}
}
EUVIMED